tiprankstipranks
Trending News
More News >
Elekta AB (EKTAY)
OTHER OTC:EKTAY

Elekta AB (EKTAY) Price & Analysis

Compare
25 Followers

EKTAY Stock Chart & Stats

$6.37
-$0.10(-1.78%)
At close: 4:00 PM EST
$6.37
-$0.10(-1.78%)

Elekta AB News

EKTAY FAQ

What was Elekta AB’s price range in the past 12 months?
Elekta AB lowest stock price was $4.42 and its highest was $6.37 in the past 12 months.
    What is Elekta AB’s market cap?
    Elekta AB’s market cap is $2.49B.
      When is Elekta AB’s upcoming earnings report date?
      Elekta AB’s upcoming earnings report date is Mar 05, 2026 which is in 52 days.
        How were Elekta AB’s earnings last quarter?
        Elekta AB released its earnings results on Nov 26, 2025. The company reported $0.063 earnings per share for the quarter, beating the consensus estimate of N/A by $0.063.
          Is Elekta AB overvalued?
          According to Wall Street analysts Elekta AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Elekta AB pay dividends?
            Elekta AB pays a Semiannually dividend of $0.064 which represents an annual dividend yield of 0.21%. See more information on Elekta AB dividends here
              What is Elekta AB’s EPS estimate?
              Elekta AB’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Elekta AB have?
              Elekta AB has 368,588,000 shares outstanding.
                What happened to Elekta AB’s price movement after its last earnings report?
                Elekta AB reported an EPS of $0.063 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 24.11%.
                  Which hedge fund is a major shareholder of Elekta AB?
                  Currently, no hedge funds are holding shares in EKTAY
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Elekta AB Stock Smart Score

                    4
                    Neutral
                    1
                    2
                    3
                    4
                    5
                    6
                    7
                    8
                    9
                    10

                    Technicals

                    SMA
                    Negative
                    20 days / 200 days
                    Momentum
                    -18.41%
                    12-Months-Change

                    Fundamentals

                    Return on Equity
                    2.57%
                    Trailing 12-Months
                    Asset Growth
                    1.90%
                    Trailing 12-Months

                    Company Description

                    Elekta AB

                    Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

                    Elekta AB (EKTAY) Earnings & Revenues

                    EKTAY Company Deck

                    EKTAY Earnings Call

                    Q2 2025
                    0:00 / 0:00
                    Earnings Call Sentiment|Neutral
                    The earnings call reflects a mix of positive developments and ongoing challenges. Elekta reported strong performance in Europe, growth in service business, and positive trends in China, alongside improved cash flow and debt reduction. However, challenges persist in the U.S. market, with order cancellations and gross margin recovery issues. The new operating model and cost reductions highlight a proactive approach to addressing these challenges.View all EKTAY earnings summaries
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    AptarGroup
                    Baxter International
                    Becton Dickinson
                    Hologic
                    Masimo

                    Ownership Overview

                    0.02%<0.01%99.97%
                    Insiders
                    <0.01% Other Institutional Investors
                    99.97% Public Companies and
                    Individual Investors

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks